Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

November 7, 2019November 7, 2019

Exercise Helps to Slow Motor Neuron Loss in ALS, Study Suggests, But Type of Activity May Be Key

News

Exercise appears to benefit people with amyotrophic lateral sclerosis (ALS) by normalizing molecular changes that occur at the junction of nerves and muscles, but by degrees that depend on the ... Read more

October 31, 2019

Canadian Health Professionals Recommend Stretching More, But Science Remains Shaky, Survey Finds

News

Health professionals in Canada are more likely to recommend stretching than strength or aerobic exercises to people with amyotrophic lateral sclerosis (ALS), a recent survey found. However, this approach ... Read more

October 25, 2019

Mouse Study Uncovers Role of FUS Protein in ALS Neuromuscular Junction Defects

News

FUS protein plays a role in the proper functioning and stability of the neuromuscular junction — the site of communication between motor nerves and muscle fibers — and mutations ... Read more

October 24, 2019

Phase 2 CENTAUR Trial for AMX0035 Included Most Severe ALS Patients to Maximize Statistical Power, Experts Explain in Webinar

News

The Phase 2 CENTAUR trial testing AMX0035 for amyotrophic lateral sclerosis (ALS) was designed to include patients with the most severe disease to yield the most powerful results possible, ... Read more

October 11, 2019November 13, 2019

Harvard Researcher Wins 2019 AANEM Scientific Impact Award for Study of Fingolimod in ALS

News

A Harvard Medical School professor and scientist, Sabrina Paganoni, has won the 2019 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Scientific Impact Award for her work in a Phase ... Read more

September 20, 2019September 25, 2019

Study Suggests Mechanism for ALS Caused by Toxic Algae-produced Compound

News

A toxin produced by algae may contribute to the development of amyotrophic lateral sclerosis (ALS) by lowering the stability of a protein in the brain, a new study suggests. ... Read more

September 18, 2019September 18, 2019

FTC Warns Companies Against Unsubstantiated Advertising of CBD Products for ALS

News

The U.S. Federal Trade Commission (FTC) sent warning letters to three companies that sell cannabis-based products containing cannabidiol (CBD), cautioning them that making unsubstantiated claims about the health benefits ... Read more

September 9, 2019September 11, 2019

Study Supports Cdk5 as Therapeutic Target for ALS

News

Inhibition of a protein called Cdk5 in the brain increases lifespan and improves motor function in mice with amyotrophic lateral sclerosis (ALS), a new study reports. This evidence supports ... Read more

September 3, 2019September 5, 2019

Measures of Lung Health Help to Predict Likely Outcomes in ALS Patients, Study Suggests

News

Measuring lung function can help to predict overall disease progression in people with amyotrophic lateral sclerosis (ALS), a study suggests. “Classifying Amyotrophic Lateral Sclerosis Patients by Changes in Forced ... Read more

August 26, 2019September 5, 2019

New Dynamic Neck Brace May Improve Head, Neck Range of Motion for ALS Patients, Study Says

News

A newly developed robotic neck brace may improve quality of life for people with amyotrophic lateral sclerosis (ALS) and allow researchers a more detailed assessment of head and neck ... Read more

Pin It on Pinterest